ONCO/Reveal Solid Tumor Panel

The ONCO/Reveal Solid Tumor Panel is a robust 47-gene assay that simultaneously tests for key mutations present in solid tumors, including NSCLC, colorectal, pancreatic, GIST, thyroid cancer, melanomas and gliomas. Additionally, genes with potential importance in immuno-oncology such as POLD1 and POLE are analyzed. The panel uses proprietary Stem-Loop Inhibition-Mediated amplification (SLIMamp®) technology for efficient single-tube target enrichment.

Benefits:

  • Requires as little as 2.5 ng of input DNA
  • Detection of 1% allele frequency in somatic cancers
  • Single sample / single well assay technology for enhanced sensitivity
  • Automatable sample processing
Solid Tumor Panel Target Genes (47 in total)
AKT1 CYSLTR2 FBXW7 GNAS KIT PDGFRA PTPN11 SRSF2
ALK DDR2 FGFR1 H3F3A KRAS PIK3CA RAC1 STK11
ARAF EGFR FGFR2 HIST1H3B MAP2K1 PLCB4 RAF1 TERT
BRAF EIF1AX FGFR3 HRAS MET POLD1 RET TP53
CDKN2A ERBB2 GNA11 IDH1 NRAS POLE SF3B1 TSHR
CTNNB1 ERBB4 GNAQ IDH2 NTRK1 PTEN SMAD4  
 
 Please feel free to contact us with any questions or requests.

For Research Use Only. Not for diagnostic procedures.